This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Clear Cell Renal Cell Carcinoma or Stage I Renal Cell Cancer
and you are
over 18
years old
This is an early phase trial to investigate
how or whether the drug affects your body.
Show me locations

The purpose

This pilot phase 0 trial studies how well enzalutamide works before surgery in treating patients with kidney cancer. Androgens are a type of hormone produced by the body that may cause kidney tumors to grow. Anti-hormone therapy, such as enzalutamide, may lessen the amount of androgens produced by the body and keep kidney tumors from growing.

Provided treatments

  • Drug: Enzalutamide
  • Other: Laboratory Biomarker Analysis
  • Procedure: Nephrectomy

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02885649. The sponsor of the trial is Rutgers, The State University of New Jersey and it is looking for 3 volunteers for the current phase.
Official trial title:
Pilot Study of the Blockade of Androgens in Renal Cell Carcinoma Using Enzalutamide (BARE)